We are live on ! Find out more
ACM

Aurdan Capital Management Portfolio holdings

AUM $394M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+19.7%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$294M
AUM Growth
+$28.1M
Cap. Flow
+$14.8M
Cap. Flow %
5.05%
Top 10 Hldgs %
57.52%
Holding
92
New
8
Increased
26
Reduced
35
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 12.4%
2 Consumer Staples 8.46%
3 Financials 7.39%
4 Consumer Discretionary 6.61%
5 Industrials 5.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IUSG icon
1
iShares Core S&P US Growth ETF
IUSG
$31.7B
$43.2M 14.71%
287,044
+976
+0.3% +$132K
IVV icon
2
iShares Core S&P 500 ETF
IVV
$872B
$29.6M 10.07%
47,604
+738
+2% +$424K
VIG icon
3
Vanguard Dividend Appreciation ETF
VIG
$111B
$27.2M 9.28%
133,018
+23,383
+21% +$4.53M
VXF icon
4
Vanguard Extended Market ETF
VXF
$30.3B
$13.5M 4.59%
69,870
+4,607
+7% +$818K
VGIT icon
5
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$10.7M 3.66%
+179,614
New +$10.6M
PM icon
6
Philip Morris
PM
$297B
$9.86M 3.36%
54,153
-1,092
-2% -$188K
GWW icon
7
W.W. Grainger
GWW
$65.3B
$9.29M 3.17%
8,935
-293
-3% -$304K
COR icon
8
Cencora
COR
$60.6B
$9.04M 3.08%
30,162
-1,550
-5% -$447K
MRSH
9
Marsh
MRSH
$90.5B
$8.32M 2.84%
38,070
-1,213
-3% -$274K
LOW icon
10
Lowe's Companies
LOW
$117B
$8.13M 2.77%
36,665
-2,503
-6% -$559K
ROST icon
11
Ross Stores
ROST
$80.5B
$5.81M 1.98%
45,548
-3,166
-6% -$439K
MCHP icon
12
Microchip Technology
MCHP
$40.3B
$5.42M 1.85%
76,998
-11,469
-13% -$630K
ABT icon
13
Abbott
ABT
$183B
$5.04M 1.72%
37,064
-925
-2% -$122K
CGDV icon
14
Capital Group Dividend Value ETF
CGDV
$37.7B
$4.98M 1.7%
126,191
+35,307
+39% +$1.28M
UNH icon
15
UnitedHealth
UNH
$376B
$4.94M 1.68%
15,846
-1,424
-8% -$544K
AMGN icon
16
Amgen
AMGN
$208B
$4.72M 1.61%
16,901
-4,937
-23% -$1.4M
STT icon
17
State Street
STT
$50.6B
$4.43M 1.51%
41,693
-2,317
-5% -$214K
CVX icon
18
Chevron
CVX
$392B
$4.05M 1.38%
28,296
-2,045
-7% -$288K
CGGR icon
19
Capital Group Growth ETF
CGGR
$23.8B
$3.93M 1.34%
96,701
-840
-0.9% -$30.7K
JNJ icon
20
Johnson & Johnson
JNJ
$618B
$3.71M 1.26%
24,280
-2,236
-8% -$344K
GPIQ icon
21
Goldman Sachs ETF Trust Goldman Sachs Nasdaq-100 Premium Income ETF
GPIQ
$5.1B
$3.4M 1.16%
68,187
+53,869
+376% +$2.48M
SYY icon
22
Sysco
SYY
$40.8B
$3.36M 1.15%
44,392
-5,722
-11% -$415K
JGRO icon
23
JPMorgan Active Growth ETF
JGRO
$9.37B
$3.28M 1.12%
38,095
+7,649
+25% +$595K
APD icon
24
Air Products & Chemicals
APD
$65.7B
$3.28M 1.12%
11,614
-2,061
-15% -$564K
MSFT icon
25
Microsoft
MSFT
$3.45T
$3.19M 1.09%
6,421
+102
+2% +$44.3K

Similar funds

Aurdan Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Aurdan Capital Management held 92 positions worth $294M, up 11% from $265M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Aurdan Capital Management deployed $14.8M of net new capital in Q2 2025, opening 8 new positions and adding to 26 existing holdings. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 179,614 shares worth $10.7M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Amgen, an estimated $1.4M trimmed.

  • Aurdan Capital Management's largest Q2 2025 buy was Vanguard Intermediate-Term Treasury ETF: 179,614 shares worth $10.7M.
  • Aurdan Capital Management added most to Vanguard Dividend Appreciation ETF in Q2 2025, an estimated $4.53M increase.
  • Aurdan Capital Management's biggest Q2 2025 reduction was Amgen, cutting an estimated $1.4M.
  • Aurdan Capital Management fully exited J.M. Smucker in Q2 2025, selling an estimated $639K.
  • Aurdan Capital Management's ten largest holdings make up 58% of its $294M portfolio in Q2 2025.
  • Aurdan Capital Management opened 8 new positions and closed 4 in Q2 2025.
  • Aurdan Capital Management's portfolio value rose 11% quarter-over-quarter to $294M.

Based on Aurdan Capital Management's 13F filing for Q2 2025, filed 5 Aug 2025.